Skip to content

The mechanism based on intestinal microecology and metabolomics and clinical application for obesity sarcopenia in the elderly

The mechanism based on intestinal microecology and metabolomics and clinical application for obesity sarcopenia in the elderly

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200064721
Enrollment
Unknown
Registered
2022-10-15
Start date
2022-10-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcopenic Obesity

Interventions

Case series:None

Sponsors

Beijing hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 120 Years

Inclusion criteria

Inclusion criteria: 1. Age>=40 years; 2. No acute infectious diseases; 3. Fatal diseases without progression; 4. No mental illness; 5. No history of alcohol or drug abuse; 6. No criminal record; 7. Sign informed consent and be willing to undergo BIA testing and gut microbiota testing.

Exclusion criteria

Exclusion criteria: 1. Age<40 years; 2. Those who have any physical or mental functional issues and are unable to complete this survey; 3. Use of antibiotics, probiotics, prebiotics or synbiotics, proton pump inhibitors, or radiation therapy or chemotherapy within 2 months prior to admission.

Design outcomes

Primary

MeasureTime frame
sarcopenic obesity;

Countries

China

Contacts

Public ContactYuting Kang

Beijing hospital

kangyuting02@163.com+86 15811562800

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026